These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7317170)

  • 1. Importance of pharmaceutical formulation for dermatological preparations.
    Ross G
    Boll Chim Farm; 1981 Aug; 120(8):437-57. PubMed ID: 7317170
    [No Abstract]   [Full Text] [Related]  

  • 2. Formulation aspects on dermatological preparations and transdermal drug delivery systems.
    Junginger HE
    Acta Pharm Nord; 1992; 4(2):117. PubMed ID: 1388757
    [No Abstract]   [Full Text] [Related]  

  • 3. [Approach to the technologic and biopharmaceutic evaluation of dermatological preparations].
    Curcio L; Rigamonti S
    Boll Chim Farm; 1971 Aug; 110(8):421-7. PubMed ID: 5137980
    [No Abstract]   [Full Text] [Related]  

  • 4. [Topical therapy in dermatology: pharmaceutical forms, excipients and bases for magistral preparations].
    Vennat B; Pouget MP; Pourrat A
    Ann Dermatol Venereol; 2000 Jan; 127(1):110-21. PubMed ID: 10717577
    [No Abstract]   [Full Text] [Related]  

  • 5. [Study of the performances of Unguator mixing equipments for the pharmaceutical compounding of dermatological dosage forms].
    Stassen T; Piette M; Kinget R; Delattre L
    J Pharm Belg; 2006; 61(1):1-10. PubMed ID: 16669341
    [No Abstract]   [Full Text] [Related]  

  • 6. [Considerations on dermatological magistral preparations].
    Oslet J
    J Pharm Belg; 1966; 21(3):163-202. PubMed ID: 5914546
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pastes and individual formulations].
    Hautarzt; 2010 Dec; 61(12):1010-11. PubMed ID: 21125369
    [No Abstract]   [Full Text] [Related]  

  • 8. [Glucocorticoid containing extemporaneous formulations. Rational for use in dermatology].
    Högger P
    Pharm Unserer Zeit; 2010 Jul; 39(4):294-9. PubMed ID: 20589803
    [No Abstract]   [Full Text] [Related]  

  • 9. [Influence of excipients on glucocorticoid determination in dermatological preparations].
    Halot D; Lanson M
    Ann Pharm Fr; 1971 Nov; 29(11):533-9. PubMed ID: 5138616
    [No Abstract]   [Full Text] [Related]  

  • 10. Scheele lecture. Biopharmaceutical aspects of drug formulation.
    Davis SS
    Acta Pharm Suec; 1986; 23(5):305-14. PubMed ID: 3565033
    [No Abstract]   [Full Text] [Related]  

  • 11. [Aerosol cans--a new method of application of dermatological preparations].
    Tsetlin VM; Eĭdel'shteĭn SI
    Vestn Dermatol Venerol; 1968 Feb; 42(2):30-3. PubMed ID: 5741226
    [No Abstract]   [Full Text] [Related]  

  • 12. [Formulation of HIV protease inhibitors. Pharmaceutical technology and biopharmaceutic aspects of HIV protease inhibitors].
    Leopold CS
    Pharm Unserer Zeit; 2001; 30(3):234-9. PubMed ID: 11400673
    [No Abstract]   [Full Text] [Related]  

  • 13. Galenics of dermal products--vehicles, properties and drug release.
    Daniels R; Knie U
    J Dtsch Dermatol Ges; 2007 May; 5(5):367-83. PubMed ID: 17451381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Some factors affecting bioavailability of drug products.
    Lach JL
    J Iowa Med Soc; 1972 Aug; 62(8):441-2 passim. PubMed ID: 5044776
    [No Abstract]   [Full Text] [Related]  

  • 15. [Drug surveillance and topical drugs].
    Roujeau JC
    Ann Dermatol Venereol; 1996; 123(10):624-5. PubMed ID: 9615120
    [No Abstract]   [Full Text] [Related]  

  • 16. [Quality skin care preparations in the pharmacy. Tailor-made medicine--patient-friendly and safe].
    Lichtblau V; Plener HU
    Pharm Unserer Zeit; 2010 Jul; 39(4):300-5. PubMed ID: 20589804
    [No Abstract]   [Full Text] [Related]  

  • 17. [Standard prescriptions for the formulation of medicinal preparations in pharmacies V. The collection Dermatologische Magistralrezepturen der Schweiz].
    Subert J; Kolár J
    Ceska Slov Farm; 2012 Aug; 61(4):159-62. PubMed ID: 23251957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Magistral preparations in dermatology].
    Poli F; Revuz J
    Ann Dermatol Venereol; 1986; 113(12):1295-300. PubMed ID: 3566077
    [No Abstract]   [Full Text] [Related]  

  • 19. Multivesicular emulsion: a novel, controlled-release delivery system for topical dermatological agents.
    Bikowski J; Shroot B
    J Drugs Dermatol; 2006; 5(10):942-6. PubMed ID: 17373142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopharmaceutics and drug standards.
    Feldmann EG
    Am J Hosp Pharm; 1968 Mar; 25(3):111-9. PubMed ID: 5658858
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.